Now Reading
PediaMed Ranked #1 Place to Work in Kentucky
PediaMed Ranked #1 Place to Work in Kentucky
Published 04-08-05
Submitted by PediaMed
The rankings were announced on March 23 during an awards luncheon and winners were determined following an assessment of participating company's employee policies and procedures and the results of an internal survey of employees.
"With more than 80 companies nominated this year, we are honored to be selected as the number one place to work in Kentucky in the mid-size company category," says Cameron Durrant, MD, MBA, President, PediaMed Pharmaceuticals. "This award truly recognizes the employees, and the positive company culture that has been put into place since day one."
To nurture the winning culture, the company emphasizes five top-tier behaviors: Shared accountability and transparency; participative management; ongoing listening and learning; continuous improvement; and coaching and supporting others.
In addition to its growing staff including over 100 employees in marketing and sales, PediaMed also continues to build its product portfolio through its clinical development pipeline. This pipeline currently includes an investigational drug entering Phase II clinical trials for gastrointestinal dysfunction in autistic children, and innovative drug-delivery systems.
"PediaMed is a growing company in one of the most livable areas in America," says Debbie Broughton, SPHR, Head, Organizational Development and HR, PediaMed Pharmaceuticals, "and we look forward to continued employee success both personally and professionally."
The Best Places to Work initiative was launched in July 29, 2004 and is dedicated to finding and recognizing Kentucky's best employers.
About PediaMed - The Pediatrics Company(TM)
PediaMed Pharmaceuticals, Inc. - The Pediatrics Company(TM) is a privately held, specialty pharmaceutical company focused on providing safe and effective medicine to pediatric patients, parents and the healthcare professionals that serve them. In just a few short years the company has been able to establish a 100+-person sales and marketing team and achieve profitability. The company has also established a significant development pipeline and has extensive pediatric clinical development and regulatory expertise. Net sales have quadrupled in the last two years.
PediaMed today focuses on providing Kidpliant(TM) prescription medicines in the field of allergy/cough/cold and in promoting Tazorac(R) acne cream and gel, ZYMAR(R) ophthalmic solution, and Clarinex(R) Syrup and Tablets, through recently established co-marketing arrangements with Allergan and Schering Plough Corporation. In keeping with its mission, the company is identifying underserved pediatric market opportunities in the areas of respiratory/allergy, anti-infectives, gastroenterology, dermatology and central nervous system (CNS). The company is in the process of acquiring new products/opportunities to leverage its core sales and marketing competency focused in the highly underserved and rapidly growing pediatric market.
With recent changes in the regulatory landscape regarding pediatric pharmaceuticals, the company believes that the opportunities are many and growing, and it is well positioned to take full advantage of these opportunities with pediatrics now established as the fastest growing prescription segment.
Founded in 1999, PediaMed is a member of the Union Springs, L.L.C. portfolio of companies. For more information, visit the PediaMed Web site at www.pediamedpharma.com.
